Phibro Animal Health Corp. (PAHC)
38.82
+0.84
(+2.21%)
USD |
NASDAQ |
Oct 16, 16:00
38.83
+0.01
(+0.03%)
After-Hours: 20:00
Phibro Animal Health Free Cash Flow (Quarterly) : 5.225M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.225M |
| March 31, 2026 | 0.89M |
| December 31, 2025 | 8.255M |
| September 30, 2025 | -4.504M |
| June 30, 2025 | 8.13M |
| March 31, 2025 | 35.41M |
| December 31, 2024 | -4.746M |
| September 30, 2024 | 3.039M |
| June 30, 2024 | 15.36M |
| March 31, 2024 | 1.677M |
| December 31, 2023 | 20.60M |
| September 30, 2023 | 8.723M |
| June 30, 2023 | 9.347M |
| March 31, 2023 | -1.649M |
| December 31, 2022 | -12.31M |
| September 30, 2022 | -33.87M |
| June 30, 2022 | -10.32M |
| March 31, 2022 | -3.883M |
| December 31, 2021 | 12.43M |
| September 30, 2021 | -3.628M |
| June 30, 2021 | -4.024M |
| March 31, 2021 | 9.137M |
| December 31, 2020 | 19.60M |
| September 30, 2020 | -5.722M |
| June 30, 2020 | -6.199M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.10M |
| December 31, 2019 | 23.65M |
| September 30, 2019 | -11.24M |
| June 30, 2019 | 4.762M |
| March 31, 2019 | 7.997M |
| December 31, 2018 | 9.288M |
| September 30, 2018 | -4.769M |
| June 30, 2018 | 4.58M |
| March 31, 2018 | 18.64M |
| December 31, 2017 | 28.44M |
| September 30, 2017 | -0.195M |
| June 30, 2017 | 8.072M |
| March 31, 2017 | 32.26M |
| December 31, 2016 | 21.62M |
| September 30, 2016 | 15.54M |
| June 30, 2016 | 18.89M |
| March 31, 2016 | -5.973M |
| December 31, 2015 | -1.561M |
| September 30, 2015 | -10.49M |
| June 30, 2015 | 14.91M |
| March 31, 2015 | 15.70M |
| December 31, 2014 | 4.65M |
| September 30, 2014 | 13.38M |
| June 30, 2014 | -22.94M |
| March 31, 2014 | -4.25M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Globus Medical, Inc. | 176.57M |
| Corcept Therapeutics, Inc. | 31.02M |
| Zoetis, Inc. | 538.00M |
| Abbott Laboratories | 1.991B |
| Prestige Consumer Healthcare, Inc. | 67.08M |